Home » Headlines » Currently Reading:

Morning Headlines 11/21/13

November 21, 2013 Headlines No Comments

FDA approves next gen sequencers in watershed for personalized med

The FDA has cleared toe manufacturers of four next generation high-throughput DNA sequencers to market the devices to help identify gene mutations that are linked with cystic fibrosis.

Children’s Oakland completes Phase 1 of $89 million electronic records system

Children’s Hospital & Research Center in Oakland (CA) goes live with its $89 million Epic rollout across its inpatient and oncology/hematology clinics. The remainder of its ambulatory clinics are scheduled to go live in April.

Health dept pleads for PCEHR patience

In Australia, Department of Health secretary Jane Halton is asking for patience as the nations newly elected Prime Minister calls for a review of the nations failing $1 billion patient-controlled EHR portal program. To date, only 11,136 shared health summaries had been uploaded into the system despite being live for more than a year.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Wayne Gillis' LinkedIn post. Neither Rehoboth McKinley or Great Falls Clinic is on Epic. Did he miss a workplace on…

  2. Good DTC discussion a few weeks ago on LinkedIn: https://www.linkedin.com/posts/graham-walker-md_what-if-we-made-a-lot-more-tests-direct-to-consumer-activity-7426998007272861697-ZCGP?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAGYl5gBhHG9z_iLVKPFLIJzVxbfDeN79Is Also distinctions between DTC and Direct Access Testing (DAT): https://myadlm.org/cln/cln-daily/2023/direct-to-consumer-laboratory-testing…

  3. The link to Wayne Gillis' post doesn't seem to work, though I did find it through searching directly in LinkedIn.…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.